Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (435)	3/10/1998 8:40:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 569

Curtis - <<but this tells you why biox and anik may be languishing and why sales may be less than we might expect.>> Tiger, not even close. (1) Anik can't move. And when it can move - it will. (2) I expected BIOX to ship $5.5 mil. of Synvisc in the 4th Qtr. I am guessing they actually shipped $4.6 mil. Sound bad? Sure, until you realize they only shipped 2 months worth. (Yes, I am guessing at this.) I am confident nonetheless. Janet L. who already owns 1.1 million shares of BIOX just bought $175,000 worth - at $35.00 a pop - on 2/13/98. Note - her husband owns an additional 2.2 million shares. I am pretty certain, but not absolutely certain, that these shares are above and beyond the shares in senior management's restricted stock plan which she can acquire at considerably less than $35.00 a pop. Do you see? These people are not screwing around. Moreover, she ALREADY knows what 1st qtr. Synvisc sales will be. (She's Exec VP) In addition, I am telling you point blank - but without support - that some (O's) could not get all the product they wanted in the 4th qtr. I am also telling you that some (O's) have a hard-on for this stuff- Synvisc. Why? They finally feel like they can help their patients. (Almost a quote) Roughly speaking, its POINT and SHOOT time out there. Lastly, and this will piss you off, I am going to put a few more cards on the table. I've been investing a long time. I am very acquainted with Orthologic. Without doubt - my opinion - one of the truly scummy companies on the planet. A cockaroach has more ethics. And that is why, I was/am suspect when I heard they were peddling Hyalgan. I am not knocking the product. FDA said it works. Nuff said. You should read about Orthologic. Start with the SEC from a few years ago. I don't have any links. Your (R) friend in San Fran? Whatever thing she has going - great. But, like the Titanic, the end game in this a foregone conclusion. Regards, John